Background : Tryptophan metabolites such as serotonin, kynurenine, or kynurenic acids are considered to be the most important metabolites of gut microbiota. We wanted to know about changes in tryptophan metabolites in various diseases in which the etiology gut microbiota are considered to participate. Methods : Ultra-high speed liquid chromatography/mass spectroscopy (LC/MS) has been used to analyze simultaneously all the tryptophan metabolites, which we have explored for the first time in the world. Results : We analyzed plasma levels of tryptophan metabolites in patients with depression, autism, diabetes mellitus ‘DM ’ ), and acute coronary syndrome (ACS). Of all the metabolites serotonin and kynurenine levels of these patients were higher than those of controls. Conclusion : Measurements of tryptophan metabolites in plasma of various diseases are important to know roles of gut microbiota in etiology, further therapeutic measures.
Sender, R., Fuchs, S. and Milo, R. (2016) Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell, 164, 337-340. https://doi.org/10.1016/j.cell.2016.01.013
Yoo, B.B. and Mazmanian, S.K. (2017) The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. Immunity, 46, 910-926. https://doi.org/10.1016/j.immuni.2017.05.011
Ruan, W., Engevik, M.A., Spinler, J.K. and Versalovic, J. (2020) Healthy Human Gastrointestinal Microbiome: Composition and Function after a Decade of Exploration. Digestive Diseases and Sciences, 65, 695-705. https://doi.org/10.1007/s10620-020-06118-4
Thursby, E. and Juge, N. (2017) Introduction to the Human Gut Microbiota. Biochemical Journal, 474, 1823-1836. https://doi.org/10.1042/BCJ20160510
Lloyd-Price, J., Arze, C., Ananthakrishnan, A.N., Schirmer, M., Avila-Pacheco, J., Poon, T.W., et al. (2019) Multi-Omics of the Gut Microbial Ecosystem in Inflammatory Bowel Diseases. Nature, 569, 655-662. https://doi.org/10.1038/s41586-019-1237-9
Li, L., Jing, Q., Yan, S., Liu, X., Sun, Y., Zhu, D., Wang, D., Hao, C. and Xue, D. (2021) Amadis: A Comprehensive Database for Association between Microbiota and Disease. Frontiers in Physiology, 12, Article ID: 697059.
Mitchell, A.J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C. and Meader, N. (2011) Prevalence of Depression, Anxiety, and Adjustment Disorder in Oncological, Haematological, and Palliative-Care Settings: A Meta-Analysis of 94 Interview-Based Studies. The Lancet Oncology, 12, 160-174. https://doi.org/10.1016/S1470-2045(11)70002-X
Jacobs, B.L., Fornal, C.A. and Wilkinson, L.O. (1990) Neurophysiological and Neurochemical Studies of Brain Serotonergic Neurons in Behaving Animals. Annals of the New York Academy of Sciences, 600, 260-268. https://doi.org/10.1111/j.1749-6632.1990.tb16888.x
Jacobs, B.L. and Fornal, C.A. (1991) Activity of Brain Serotonergic Neurons in the Behaving Animal. Pharmacological Reviews, 43, 563-578.
Delgado, P.L., Charney, D.S., Price, L.H., Aghajanian, G.K., Landis, H. and Heninger, G.R. (1990) Serotonin Function and the Mechanism of Antidepressant Action. Reversal of Antidepressant-Induced Remission by Rapid Depletion of Plasma Tryptophan. Archives of General Psychiatry, 47, 411-418. https://doi.org/10.1001/archpsyc.1990.01810170011002
Delgado, P.L., Price, L.H., Miller, H.L., Salomon, R.M., Aghajanian, G.K., Heninger, G.R. and Charney, D.S. (1994) Serotonin and the Neurobiology of Depression. Effects of Tryptophan Depletion in Drug-Free Depressed Patients. Archives of General Psychiatry, 51, 865-784. https://doi.org/10.1001/archpsyc.1994.03950110025005
Benkert, O., Szegedi, A. and Wetzel, H. (1996) Minimum Effective Dose for Antidepressants—An Obligatory Requirement for Antidepressant Drug Evaluation? International Clinical Psychopharmacology, 11, 177-185. https://doi.org/10.1097/00004850-199609000-00004
Moncrieff, J., Cooper, R.E., Stockmann, T., Amendola, S., Hengartner, M.P. and Horowitz, M.A. (2022) The Serotonin Theory of Depression: A Systematic Umbrella Review of the Evidence. Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01661-0
Bach, H., Huang, Y.Y., Underwood, M.D., Dwork, A.J., Mann, J.J. and Arango, V. (2014) Elevated Serotonin and 5-HIAA in the Brainstem and Lower Serotonin Turnover in the Prefrontal Cortex of Suicides. Synapse, 68, 127-130. https://doi.org/10.1002/syn.21695
Tomioka, H., Masuda, J., Takada, A. and Iwanami, A. (2020) Differences of Plasma Levels of Tryptophan, Serotonin, 5-Hydroxyindole Acetic Acid, and Kynurenine between Healthy People and Patients of Major Monopolar Depression at Various Age and Gender. Food and Nutrition Sciences, 11, 431-441. https://doi.org/10.4236/fns.2020.116031
Tomioka, H., Masuda, J., Takada, A. and Iwanami, A. (2020) Comparison of Age and Gender Differences of Tryptophan Metabolites in Patients of Major Monopolar and Bipolar Depression. Food and Nutrition Sciences, 11, 172-185. https://doi.org/10.4236/fns.2020.113013
Tomioka, H., Masuda, J., Takada, A. and Iwanami, A. (2020) Studies on Tryptophan Metabolites in Patients of Major Monopolar Depression. In: Vlachou, M., Ed., Melatonin, IntechOpen, London, 133-141. https://doi.org/10.5772/intechopen.91967
Tomioka, H., Masuda, J., Takada, A. and Iwanami, A. (2020) Comparison of Plasma Levels of Tryptophan Metabolites between Healthy People and Patients of Bipolar Depression at Various Age and Gender. Journal of Biomedical Science and Engineering, 13, 120-129. https://www.scirp.org/journal/jbise https://doi.org/10.4236/jbise.2020.136012
Takada, A., Shimizu, F., Ishii, Y., Ogawa, M. and Takao, T. (2019) Plasma Levels of Amino Acids in Japanese Men and Their Changes after the Administration of Glucose and Sucrose. Food and Nutrition Sciences, 10, 51-63. https://doi.org/10.4236/fns.2019.101005
Ogawa, M., Shimizu, F., Ishii, Y., Takao, T. and Takada, A. (2023) Uniqueness of Tryptophan in the Transport System in the Brain and Peripheral Tissues. Food and Nutrition Sciences, 14, 401-414. https://doi.org/10.4236/fns.2023.145026
Fernstrom, J.D. and Wurtman, R.J. (1971) Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet. Science, 174, 1023-1025. https://doi.org/10.1126/science.174.4013.1023
Fernstrom, J.D. and Wurtman, R.J. (1972) Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids. Science, 178, 414-416. https://doi.org/10.1126/science.178.4059.414
Furuse, M. and Tsukita, S. (2006) Claudins in Occluding Junctions of Humans and Flies. Trends in Cell Biology, 16, 181-188. https://doi.org/10.1016/j.tcb.2006.02.006
Wolburg, H., Wolburg-Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, F., Duffner, E.H., Grote, E.H., Risau, W. and Engelhardt, B. (2003) Localization of Claudin-3 in Tight Junctions of the Blood-Brain Barrier Is Selectively Lost during Experimental Autoimmune Encephalomyelitis and Human Glioblastoma Multiforme. Acta Neuropathologica, 105, 586-592. https://doi.org/10.1007/s00401-003-0688-z
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M. and Tsukita, S. (2003) Size-Selective Loosening of the Blood-Brain Barrier in Claudin-5-Deficient Mice. Journal of Cell Biology, 161, 653-660. https://doi.org/10.1083/jcb.200302070
Young, L.W., Darios, E.S. and Watts, S.W. (2015) An Immunohistochemical Analysis of SERT in the Blood-Brain Barrier of the Male Rat Brain. Histochemistry and Cell Biology, 144, 321-329. https://doi.org/10.1007/s00418-015-1343-1
Becker, G., Da Silva, S., Sabo, A.N., Antal, M.C., Kemmel, V. and Monassier, L. (2021) Blood-Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer? Pharmaceutics, 13, Article No. 1856. https://doi.org/10.3390/pharmaceutics13111856
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T. and Van den Eynde, B.J. (2003) Evidence for a Tumoral Immune Resistance Mechanism Based on Tryptophan Degradation by Indoleamine 2,3-Dioxygenase. Nature Medicine, 9, 1269-1274. https://doi.org/10.1038/nm934
Godin-Ethier, J., Hanafi, L.A., Piccirillo, C.A. and Lapointe, R. (2011) Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives. Clinical Cancer Research, 17, 6985-6991. https://doi.org/10.1158/1078-0432.CCR-11-1331
Théate, I., van Baren, N., Pilotte, L., Moulin, P., Larrieu, P., Renauld, J.C., et al. (2015) Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues. Cancer Immunology Research, 3, 161-172. https://doi.org/10.1158/2326-6066.CIR-14-0137
Moon, Y.W., Hajjar, J., Hwu, P. and Naing, A. (2015) Targeting the Indoleamine 2,3-Dioxygenase Pathway in Cancer. The Journal for ImmunoTherapy of Cancer, 3, Article No. 51. https://doi.org/10.1186/s40425-015-0094-9
Bilir, C. and Sarisozen, C. (2017) Indoleamine 2,3-Dioxygenase (IDO): Only an Enzyme or a Checkpoint Controller? Journal of Oncological Sciences, 3, 52-56. https://doi.org/10.1016/j.jons.2017.04.001
Munn, D.H. and Mellor, A.L. (2013) Indoleamine 2,3-Dioxygenase and Metabolic Control of Immune Responses. Trends in Immunology, 34, 137-143. https://doi.org/10.1016/j.it.2012.10.001
Van Baren, N. and Van den Eynde, B.J. (2015) Tryptophan-Degrading Enzymes in Tumoral Immune Resistance. Frontiers in Immunology, 6, Article No. 34. https://doi.org/10.3389/fimmu.2015.00034
Platten, M., Von Knebel Doeberitz, N., Oezen, I., Wick, W. and Ochs, K. (2015) Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors. Frontiers in Immunology, 5, Article No. 673. https://doi.org/10.3389/fimmu.2014.00673
Munn, D.H., Shafizadeh, E., Attwood, J.T., Bondarev, I., Pashine, A. and Mellor, A.L. (1999) Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism. Journal of Experimental Medicine, 189, 1363-1372. https://doi.org/10.1084/jem.189.9.1363
Johnson, T.S. and Munn, D.H. (2012) Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance. Immunological Investigations, 41, 765-797. https://doi.org/10.3109/08820139.2012.689405
Keenan, T.E., Burke, K.P. and Van Allen, E.M. (2019) Genomic Correlates of Response to Immune Checkpoint Blockade. Nature Medicine, 25, 389-402. https://doi.org/10.1038/s41591-019-0382-x
Abrahams, B.S. and Geschwind, D.H. (2008) Advances in Autism Genetics: On the Threshold of a New Neurobiology. Nature Reviews Genetics, 9, 341-355. https://doi.org/10.1038/nrg2346
Labus, J.S., Hubbard, C.S., Bueller, J., Ebrat, B., Tillisch, K., Chen, M., et al. (2013) Impaired Emotional Learning and Involvement of the Corticotropin-Releasing Factor Signaling System in Patients with Irritable Bowel Syndrome. Gastroenterology, 145, 1253-1261.e1-3. https://doi.org/10.1053/j.gastro.2013.08.016
Pandey, K.B. and Rizvi, S.I. (2009) Plant Polyphenols as Dietary Antioxidants in Human Health and Disease. Oxidative Medicine and Cellular Longevity, 2, 270-278. https://doi.org/10.4161/oxim.2.5.9498
Hay-Schmidt, A. (2000) The Evolution of the Serotonergic Nervous System. Proceedings Biological Sciences/The Royal Society, 267, 1071-1079. https://doi.org/10.1098/rspb.2000.1111
Pullikan, J., Mazumder, A. and Grace, T. (2019) Role of Gut Microbiome in Autism Spectrum Disorders. In: Guest, P.C., Ed., Reviews of Biomarker Studies in Psychiatric and Neurodegenerative Disorders, Springer, Berlin, 253-269. https://doi.org/10.1007/978-3-030-05542-4_13
Muller, C.L., Anacker, A.M.J. and Veenstra-Vander, W. (2016) The Serotonin System in Autism Spectrum Disorder: From Biomarker to Animal Models. Journal of Neuroscience, 321, 24-41. https://doi.org/10.1016/j.neuroscience.2015.11.010
Savino, R., Carotenuto, M., Polito, A.N., Di Noia, S., Albenzio, M., Scarinci, A., Ambrosi, A., Sessa, F., Tartaglia, N. and Messina, G. (2020) Analyzing the Potential Biological Determinants of Autism Spectrum Disorder: From Neuroinflammation to the Kynurenine Pathway. Brain Sciences, 10, Article No. 631. https://doi.org/10.3390/brainsci10090631
Aw, W. and Fukuda, S. (2018) Understanding the Role of the Gut Ecosystem in Diabetes Mellitus. Journal of Diabetes Investigation, 9, 5-12. https://doi.org/10.1111/jdi.12673
Aydin, O., Nieuwdorp, M. and Gerdes, V. (2018) The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. Current Diabetes Reports, 18, Article No. 55. https://doi.org/10.1007/s11892-018-1020-6
Zahiu, D.M., Zagrean, A.M. and Zagrean, L. (2016) The Association between Diabetes Mellitus and Depression. Journal of medicine and life, 9, 120-125.
Matsuoka, K., Kato, K., Takao, T., Ogawa, M., Ishii, Y., Shimizu, F., Masuda, J. and Takada, A. (2017) Concentrations of Various Tryptophan Metabolites Are Higher in Patients with Diabetes Mellitus than in Healthy Aged Male Adults. Diabetology International, 8, 69-75. https://doi.org/10.1007/s13340-016-0282-y
Roose, S.P., Glassman, A.H. and Dalack, G.W. (1989) Depression, Heart Disease, and Tricyclic Antidepressants. Journal of Clinical Psychiatry, 50, 12-16.
Anderson, S.C., Crya, J.F. and Dinan, T. (2017) The Psychobiotic Revolution. National Geographic, Washington DC.